Single-Use Technology for Biopharmaceuticals Market Size Worth USD 652.44 Billion by 2034 | CAGR: 42.11%
The global single-use technology for biopharmaceuticals market size is expected to reach USD 652.44 billion by 2034, according to a new study by Polaris Market Research. The report “Single-Use Technology for Biopharmaceuticals Market Size, Share, Trends, & Industry Analysis Report: By Product Type, By Application, By End User, and By Region; Market Forecast, 2026–2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.
The single-use technology for biopharmaceuticals market is gaining momentum as biologics developers and contract manufacturers look for faster, more adaptable ways to add production capacity. Disposable bioprocessing systems are gaining ground in facilities where product mix and batch size change often, and where speed to start-up matters as much as capital efficiency.
Buying criteria are shifting as well. Convenience alone no longer settles the decision for most biopharmaceutical manufacturers. A vendor’s quality record, documentation depth and delivery reliability now carry far more weight, which favors suppliers that can stand behind every component they ship.
Regulation is adding to this momentum. The newly effective USP <665> and <1665> standards give the industry a shared benchmark for judging product-contact materials. For vendors, that makes in-house testing capacity and thorough documentation a competitive necessity rather than a differentiator.
Questions? Request a sample or make an inquiry before buying this report by clicking the link below: Single-Use Technology for Biopharmaceuticals Market
Competition among suppliers is also intensifying. Leading bioprocessing companies are widening their downstream offerings through acquisitions and new product launches, positioning themselves as single-source partners for biomanufacturers. Customers, in turn, are gravitating toward partners that can cover more of the process, from cell culture through to purification.
Single-Use Technology for Biopharmaceuticals Market Report Highlights
- Single-use bioreactors accounted for the largest revenue share of 38.42% in 2025, anchored by steady uptake across biologics cell culture operations.
- Filtration systems are set to expand at the fastest CAGR of 43.17% from 2026 to 2034, driven by rising purification demand and sustained supplier investment in this space.
- The CDMOs & CROs segment is projected to post the fastest end-user CAGR of 46.92% over the forecast period, as sponsors hand more development and manufacturing work to external partners.
- North America accounted for the largest regional share of 34.62% in 2025, backed by deep biomanufacturing expertise and a well-developed vendor network.
- Asia Pacific is anticipated to register the fastest regional CAGR of 47.83% during the forecast period, as new bioprocessing capacity comes online across the region.
- A few global key market players include Avantor, Inc., Corning Incorporated, Danaher Corporation, Eppendorf SE, Enpro Inc., Meissner Filtration Products, Inc., Merck KGaA, Repligen Corporation, Sartorius AG, and Thermo Fisher Scientific Inc.
Single-Use Technology for Biopharmaceuticals Market report on the basis of product type, application, end user, and region:
By Product Type Outlook (Revenue, USD Billion, 2021–2034)
- Bioreactors
- Filtration Systems
- Mixing Systems
- Bags & Containers
- Chromatography Systems
- Sensors & Probes
By Application Outlook (Revenue, USD Billion, 2021–2034)
- Monoclonal Antibodies
- Vaccines
- Cell & Gene Therapies
- Therapeutic Proteins & Peptides
By End User Outlook (Revenue, USD Billion, 2021–2034)
- Biopharmaceutical Manufacturers
- CDMOs & CROs
- Academic & Clinical Research Institutes
By Regional Outlook (Revenue, USD Billion, 2021–2034)
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Netherlands
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Taiwan
- Australia
- Rest of Asia Pacific
- Latin America
- Argentina
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- UAE
- Saudi Arabia
- South Africa
- Rest of Middle East & Africa
